Detalhe da pesquisa
1.
[FRONTIERS IN CANCER PREDICTION AND EARLY DETECTION].
Harefuah;
163(2): 114-119, 2024 Feb.
Artigo
em Hebraico
| MEDLINE
| ID: mdl-38431861
2.
The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer's Disease, Amyotrophic Lateral Sclerosis and Aging.
Cells;
12(5)2023 02 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36899898
3.
IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy.
Nat Cancer;
2(10): 1055-1070, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35121883
4.
Metallocorroles as cytoprotective agents against oxidative and nitrative stress in cellular models of neurodegeneration.
J Neurochem;
113(2): 363-73, 2010 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20096090
5.
Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis.
FASEB J;
23(11): 3766-79, 2009 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19638399
6.
The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models.
Neuropharmacology;
123: 359-367, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28571715
7.
Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis.
Neurotox Res;
29(2): 208-17, 2016 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26581376
8.
Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging.
Neurobiol Aging;
36(3): 1529-42, 2015 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25499799
9.
Promises of novel multi-target neuroprotective and neurorestorative drugs for Parkinson's disease.
Parkinsonism Relat Disord;
20 Suppl 1: S132-6, 2014 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24262165
10.
The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer's disease.
Antioxid Redox Signal;
17(6): 860-77, 2012 Sep 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22360429
11.
Multi-target, neuroprotective and neurorestorative M30 improves cognitive impairment and reduces Alzheimer's-like neuropathology and age-related alterations in mice.
Mol Neurobiol;
46(1): 217-20, 2012 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22847630
12.
Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice.
Mech Ageing Dev;
133(5): 267-74, 2012 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22426424
13.
Neuroprotective multifunctional iron chelators: from redox-sensitive process to novel therapeutic opportunities.
Antioxid Redox Signal;
13(6): 919-49, 2010 Sep 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20095867
14.
Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application.
EPMA J;
1(2): 343-61, 2010 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23199069
15.
Manganese corroles prevent intracellular nitration and subsequent death of insulin-producing cells.
ACS Chem Biol;
4(11): 910-4, 2009 Nov 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19715343
16.
The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases.
J Neurochem;
103(3): 962-71, 2007 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17680997